The effect of hypoxia/reoxygenation injury is crucial in the development of NEC (
26-
28). It was seen that the administration of Vitamin E, an antioxidant, decreased histopathological damage and lowered MDA levels in rats with hypoxia-induced NEC (
28). Guven et al. (
29) compared the animals with an induced NEC model with the NEC + ozone treatment group. The mortality rate, weight loss, and histopathological injury score were significantly lower in the NEC + ozone group than in the NEC group. However, oxidative stress markers (MDA and protein carbonyl content [PCC]), nitrite + nitrate levels, and TNF-α levels were low, and antioxidant enzyme activities (SOD and GSH-Px) were higher in the NEC + ozone group than in the NEC group (
29). It has been shown that caffeic acid phenyl ester (CAPE), an antioxidant, reduces inflammation and apoptosis in the intestines of NEC-induced rats while decreasing the degenerative score and total oxidant level (
30). It has been reported that the dexpanthenol (
19) and melatonin (
31) show similar effects on NEC-induced rats. When investigating the protective effect of colchicine, an anti-inflammatory agent against NEC, MDA, TNF-α, and IL-1β levels were lower, and SOD and GSH-Px levels were higher in the NEC + colchicine group than in the NEC group. The intestinal injury score was also significantly high in the NEC group (
16). Intraperitoneal administration of N-acetyl cysteine (NAC), a free radical scavenger and antioxidant precursor, significantly reduced intestinal mucosal damage in NEC. However, a decrease in MDA, an increase in SOD, and a decrease in intestinal TNF-α were found in the NEC + NAC group than in the NEC group (
17). It was demonstrated biochemically that experimental administration of enteral surfactant yields protection against NEC in rats (
20). It has been found that intestinal alkaline phosphatase (IAP) administration decreases the degree of intestinal damage in NEC in a dose-dependent manner. It has also been reported that increased intestinal permeability in NEC is improved by IAP administration (
18). In a genetic study conducted in human cell cultures, it has been found that probiotics have protective properties in NEC (
32). We notice that antioxidants are used more in NEC-related studies. In our study, by using a molecule that is clinically used as an antioxidant, antiapoptotic, anti-inflammatory, and microcirculatory agent, we attempted to examine the effect of this molecule, which is thought to have some impacts on NEC pathophysiology.
In our literature review, we found several studies investigating the antioxidant, antiapoptotic, and anti-inflammatory effects of Hsd and diosmin. Antioxidant activity was assessed by intravenous administration of Hsd (100 mg/kg) per day in infertility associated with ovarian toxicity induced by cyclophosphamide (CP) in rats. In the CP + Hsd treatment group, NO and MDA levels and Myeloperxidase activity decreased, and SOD and GSH-Px activities increased compared to the CP group (
33). In cell culture studies, it has been shown that administration of diosmin in lipopolysaccharide (LPS)-induced apoptosis increases the proapoptotic Bad protein expression, increases antiapoptotic Bcl-2 protein expression, and enhances antiapoptotic effects by reducing LPS-induced caspase-3 activation (
34).
The drugs used in this study included 90% diosmin and 10% Hsd flavonoids. Although in several studies, it has been found that this medication is effective in reperfusion injury, the mechanism of this effect has not been fully elucidated.
In our study, it was found that flavonoid administration in rats with NEC reduced the apoptotic index and histopathologic injury score in the whole gastrointestinal system and biochemically decreased MDA in the cecum and NO in the stomach in accordance with the findings in the literature. However, contrary to the literature, our study showed that flavonoid administration reduced GSH-Px levels in the cecum. We believe that further comprehensive studies may be useful in this regard.